ezPvjlpTAvA https://histock.tw/talk/live.aspx?name=gtalk&id=1322 20250401 Queen怜

台股 » 個股 » 智擎 » 籌碼相關 » 券商分點績效

智擎

(4162)
可現股當沖
  • 股價
    97.3
  • 漲跌
    ▲1.1
  • 漲幅
    +1.14%
  • 成交量
    724
  • 產業
    上櫃 生技醫療類股
  • 309人加入追蹤

    立即追蹤

  • 本地時間:14:30(已收盤)

     
智擎 (4162)籌碼相關-券商分點績效/獲利分析
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

«前一日     2025/03/24 ~ 2025/03/31     後一日»

券商獲利排行 - 2025/03/24 ~ 2025/03/31

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  7.20%2,363.113.52,349.6-3093313104.8100.4104.997.3
  2.80%1,009.3568.6440.7-72279351102.5101.4103.497.3
  2.74%649.40649.4-2370237100010097.3
  2.22%543-4.5547.5-101137238102.7102.8102.797.3
  7.93%479.28.8470.4-53457106104106.297.3
  7.67%477.10477.1-58059105.4100.5105.497.3
  5.07%305.542.1263.4-481159102.299102.897.3
  3.16%240.7124.7116-185674102.8101.5103.797.3
  2.93%231.97.1224.8-512678101.6101.4101.697.3
  7.89%224.90224.9-27027105.60105.697.3
  6.02%1870187-30030103.50103.597.3
  4.28%181.811.7170.1-251541103.6103.1103.897.3
  3.36%116.3-9.1125.4-29434101.7103.8101.597.3
  6.39%1137.2105.8-14217104100.7104.497.3
  5.65%108.1108.5-0.411918100.797.7103.897.3
  7.16%105.610.794.9-11314105.3102.4105.997.3
  0.41%99.4-176275.4-63174237102.1102.7101.797.3
  6.14%96.90.996-12315105.2105105.397.3
  3.48%91.5-192.5-2512610110210197.3
  6.96%87.4087.4-12012104.60104.697.3
  7.33%84.7084.7-11011105010597.3
  4.57%83.448.834.6-61218101.499103.197.3
  2.48%82.93745.9-102333101.2100.3101.997.3
  6.12%82.29.173.1-11213103.399.4103.997.3
  6.31%65.5065.5-10010103.90103.997.3
  3.34%63.8063.8-18019100.7105.5100.797.3
  0.60%62.6-26.388.9-1288100104.8105104.797.3
  4.02%62.17.554.5-8615103102.1103.497.3
  2.23%621.260.8-111627102.8102.8102.897.3
  4.61%61.721.640.1-5713102.9100.910497.3
  5.38%60.826.234.6-5611102.799.9104.297.3
  6.78%56.6056.6-708104.4105.4104.497.3
  4.38%54.313.640.7-6612103.3101.8104.197.3
  2.27%53.42627.4-51823102.1101.3102.897.3
  1.06%526.345.7-83948102.3102.2102.497.3
  6.17%51.1051.1-708103.699.6103.797.3
  2.81%48.1-1.349.4-15217100.7101.3100.697.3
  6.33%4537.87.2067101.598.2104.597.3
  3.15%44.9-1.646.5-10314101.6102.1101.597.3
  4.00%44.619.425.2-5611101.299.1102.397.3
  4.25%42.8933.8-8210100.897101.597.3
  2.05%41.6-10.952.5-13720101.7102.9101.397.3
  5.10%41.65.536-718101.996.9102.497.3
  2.53%41.3-7.548.8-11416101.8103.2101.497.3
  5.60%40.4040.4-607103.1105.5103.197.3
  4.72%39.2-0.339.6-628103.9104.1103.997.3
  4.73%39-1.440.5-718103.2104.5103.197.3
  3.19%38.4038.4-11012100.597.7100.597.3
  2.96%371.435.6-5712104.3104.2104.497.3
  6.92%36036-405104.199.2104.597.3

券商虧損排行 - 2025/03/24 ~ 2025/03/31

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  -4.37%-1,584.123.7-1,607.834335512102.110210497.3
  -2.41%-88741.4-928.4169358189102.9102.810397.3
  -1.83%-647.5-78.7-568.8148350202101101.1100.897.3
  -5.42%-3790-37968680102.9102.9097.3
  -2.59%-33323.4-356.411312814100.6100.4102.197.3
  -6.35%-230.5-9.9-220.632352103.710499.197.3
  -6.74%-2110-21130300104.3104.3097.3
  -1.88%-157.527-184.5308151103.7103.410497.3
  -7.02%-147.3-1-146.31920110510510497.3
  -6.56%-1441-14520211104.6104.5105.597.3
  -3.40%-141.814-155.836414101.8101.510597.3
  -5.22%-139.40-139.426260102.7102.7097.3
  -6.41%-114.7-1.6-113.114173105.3105.4104.897.3
  -5.30%-1090-10920200102.8102.8097.3
  -1.35%-105.20-105.2-810819609697.3
  -3.39%-104.9-100.7-4.21313099.8101.598.197.3
  -7.53%-95.10-95.112120105.2105.2097.3
  -5.68%-93.70-93.715160103.2103.2106.597.3
  -8.01%-93.20-93.211110105.8105.8097.3
  -1.36%-89.4-77.5-11.94666299.7100.39997.3
  -5.38%-86.8-34.9-5210166100.9102.596.797.3
  -1.75%-82.8-109.226.4-64046103104.4101.797.3
  -2.82%-81.80-81.829290100.1100.1097.3
  -0.86%-77.7-73.6-4.108988101101.4100.697.3
  -6.37%-73.51.2-74.710111104.9104.810697.3
  -3.12%-70.8-14.3-56.592213103.2103.6102.597.3
  -4.71%-67.70.5-68.213141102.6102.510397.3
  -3.30%-67.3-70.12.801920101.9103.8100.197.3
  -4.54%-64.9-0.2-64.813141102.3102.3102.197.3
  -7.48%-61.7-16.6-45.1682103.2104.896.597.3
  -5.81%-600-6010100103.3103.3097.3
  -3.08%-59.9-59.9001919102.5104100.997.3
  -4.50%-59.60-59.613130101.9101.9097.3
  -2.29%-59.4-18.5-40.952519103.7104.1103.197.3
  -2.86%-59.2-13.6-45.762013103.4103.8102.897.3
  -3.22%-58.74-62.716181101.210110597.3
  -3.94%-56.95.5-62.510143103.3103104.897.3
  -5.99%-55.80-55.8990103.5103.5097.3
  -4.66%-53.1-1-52.18113103.7103.8103.597.3
  -2.19%-52.7-7.3-45.462317104.7104.9104.497.3
  -4.57%-51.8-36.6-15.22119103.1104.9100.897.3
  -5.42%-50.9-0.9-50792104.4104.410497.3
  -3.55%-50.7-0.2-50.511143101.9101.9101.897.3
  -2.36%-49.2-25.6-23.522017104.4105.2103.697.3
  -5.28%-48.80-48.8990102.7102.7105.597.3
  -3.93%-48.3-18-30.35127102.4103.4100.897.3
  -5.69%-470-47880103.2103.2097.3
  -7.26%-45.70-45.7660104.9104.910197.3
  -4.85%-45.5-8.1-37.4594104.2104.8102.897.3
  -5.93%-42.90-42.9770103.4103.4097.3
〈焦點股〉智擎胰腺癌新藥展望正向 股價帶量衝高Anue鉅亨-29天前
智擎胰腺癌新藥2024淨銷售額達標 5000萬美元授權金將入袋Anue鉅亨-2025/02/05
智擎 相關文章
 
 
513小時38